StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Goldenwell Biotech

Goldenwell Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Goldenwell Biotech figures

See a number that looks wrong?